MicroRNAs, mice, and Mirna Therapeutics

Over the past 24 hours there’s been media noise generated by a company called Mirna Therapeutics based on a company media release and a Letter to the Editor in Nature Medicine about how a specific piece of microRNA (miR-34) is down-regulated in prostate cancer stem cells and that this down-regulation is essential for viability of cancer stem cells. … READ MORE …

Systems biology and the development of prostate cancer

We still have little to no idea why one man gets aggressive prostate cancer, another gets indolent prostate cancer, and a third is at no risk for prostate cancer at all. … READ MORE …

Cell cycle regulation and aggressive forms of prostate cancer

A new paper by Wang et al. in a recent issue of Cancer Research has proposed details of a specific connection between control over the growth and division of prostate cancer cells and clinical occurrence of the more aggressive forms of prostate cancer. … READ MORE …

Other Wednesday prostate cancer news: February 4, 2009

In addition to the reports on the early stages of the RALP learning curve and quality of life outcomes post-brachtherapy, there are a large number of additional reports in today’s news: … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,185 other followers